Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Brain Neoplasms 12Lung Neoplasms 8Neoplasm Metastasis 7Pancreatic Neoplasms 6Liver Neoplasms 6Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Hepatocellular 5Prostatic Neoplasms 4Melanoma 4Carcinoma, Renal Cell 4Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Ovarian Neoplasms 2Neurologic Manifestations 2Glioma 2Colorectal Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor 1Stomach Neoplasms 1Spinal Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1

Interventions

pembrolizumab 3Docetaxel 3Cisplatin 3Erlotinib Hydrochloride 2Cetuximab 2Carboplatin 2spartalizumab 1ixabepilone 1entrectinib 1Vorinostat 1Tablets 1Radiotherapy 1Radiosurgery 1RC48 antibody 1Paclitaxel 1Nivolumab 1NVP-BKM120 1Ipilimumab 1Gemcitabine 1Fluorodeoxyglucose F18 1FPP(RGD)2 1Everolimus 1Epirubicin 1Combined Modality Therapy 1Chemoprevention 1Capecitabine 1CTLA-4 Antigen 1Bevacizumab 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Salivary Gland Neoplasms × Radiosurgery × Clear all
NCT03749460 2023-12-29

Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

University of Washington

Phase 1/2 Completed
20 enrolled 12 charts
Head & Neck

Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡